SEC 13F Intelligence

Waddell & Reed Financial Inc / BMRN

Waddell & Reed Financial Inc’s Biomarin Pharmaceutical Inc Position

Does Waddell & Reed Financial Inc own Biomarin Pharmaceutical Inc (BMRN)? Not currently — the last reported position was 762.8K shares worth $65M in Q2 2019; the fund’s latest 13F (Q1 2021) no longer reports it.

Position Value
$65M
Q2 2019
Shares
762.8K
% of Portfolio
+0.16%
Quarters Held
3
position exited

Position History BMRN

Reported value by quarter
Q4 ’18: $244MQ4 ’18Q1 ’19: $224MQ1 ’19Q2 ’19: $65MQ2 ’19filingsflow.com
QuarterSharesValue% of Portfolio
Q2 2019762.8K$65M+0.16%
Q1 20192.52M$224M+0.55%
Q4 20182.86M$244M+0.69%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Waddell & Reed Financial Inc’s full portfolio or all institutional holders of BMRN.